Main menu button

Actualités

Equity Research ALM Equity, Q2 2024: Back to boom margins
18 Juil 2024
Equity Research ALM Equity, Q2 2024: Back to boom margins
Equity Research ALM Equity
Equity research, Viva Wine Group: We expect a slight improvement in EBITA-margin in Q2 2024
15 Juil 2024
Equity research, Viva Wine Group: We expect a slight improvement in EBITA-margin in Q2 2024
Equity Research Viva Wine Group
Equity research HANZA: Preview Q2, 2024
12 Juil 2024
Equity research HANZA: Preview Q2, 2024
Equity Research Hanza
Research update Biosergen: Taking the next clinical step
05 Juil 2024
Research update Biosergen: Taking the next clinical step
Equity Research Biosergen
Equity research Zinzino: Solid growth in Q2 and M&A on the agenda
04 Juil 2024
Equity research Zinzino: Solid growth in Q2 and M&A on the agenda
Equity Research Zinzino
Mrkt BUZZ InCoax: Financial targets underpin our growth expectations
26 Juin 2024
Mrkt BUZZ InCoax: Financial targets underpin our growth expectations
Equity Research InCoax
Equity Research Nosa Plugs: New orders and distributor agreements
20 Juin 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Equity Research Nosa Plugs
Equity research Artificial Solutions: Improved financial strength and proven investor interest
20 Juin 2024
Equity research Artificial Solutions: Improved financial strength and proven investor interest
Equity Research Teneo AI
Equity research Svenska Aerogel: New pilot orders and improved finances
20 Juin 2024
Equity research Svenska Aerogel: New pilot orders and improved finances
Equity Research Svenska Aerogel
Equity Research Biosergen: Study permission received, BSG005 ready for testing in patients
11 Juin 2024
Equity Research Biosergen: Study permission received, BSG005 ready for testing in patients
Equity Research Biosergen
Equity research Enrad: Continued strong order intake bodes well for 2024
10 Juin 2024
Equity research Enrad: Continued strong order intake bodes well for 2024
Equity Research Enrad
Equity research, Artificial Solutions: Enabling contact centre excellence through AI
10 Juin 2024
Equity research, Artificial Solutions: Enabling contact centre excellence through AI
Equity Research Teneo AI
Equity Research ALM Equity, Q1 2024: 30% NAV discount after price fall
03 Juin 2024
Equity Research ALM Equity, Q1 2024: 30% NAV discount after price fall
Equity Research ALM Equity
Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
31 Mai 2024
Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
Equity Research Abera Bioscience
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
30 Mai 2024
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
Equity Research ALM Equity
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
23 Mai 2024
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
Equity Research Abera Bioscience
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
23 Mai 2024
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
Equity Research Zinzino
Equity research Zinzino, Q1 2024: Growth and some scalability
22 Mai 2024
Equity research Zinzino, Q1 2024: Growth and some scalability
Equity Research Zinzino
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
22 Mai 2024
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
Equity Research Carlsquare
Equity Research GIAB, Q1 2024: Third savings programme to break even
21 Mai 2024
Equity Research GIAB, Q1 2024: Third savings programme to break even
Equity Research